These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33186568)

  • 1. Chronic oral methylphenidate treatment in adolescent rats promotes dose-dependent effects on NMDA receptor binding.
    Jalloh K; Roeder N; Hamilton J; Delis F; Hadjiargyrou M; Komatsu D; Thanos PK
    Life Sci; 2021 Jan; 264():118708. PubMed ID: 33186568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats.
    Robison LS; Ananth M; Hadjiargyrou M; Komatsu DE; Thanos PK
    J Neural Transm (Vienna); 2017 May; 124(5):655-667. PubMed ID: 28116523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekday-only chronic oral methylphenidate self-administration in male rats: Reversibility of the behavioral and physiological effects.
    Carias E; Fricke D; Vijayashanthar A; Smith L; Somanesan R; Martin C; Kalinowski L; Popoola D; Hadjiargyrou M; Komatsu DE; Thanos PK
    Behav Brain Res; 2019 Jan; 356():189-196. PubMed ID: 30149034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic oral methylphenidate treatment increases microglial activation in rats.
    Carias E; Hamilton J; Robison LS; Delis F; Eiden R; Quattrin T; Hadjiargyrou M; Komatsu D; Thanos PK
    J Neural Transm (Vienna); 2018 Dec; 125(12):1867-1875. PubMed ID: 30238340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior.
    Thanos PK; Robison LS; Steier J; Hwang YF; Cooper T; Swanson JM; Komatsu DE; Hadjiargyrou M; Volkow ND
    Pharmacol Biochem Behav; 2015 Apr; 131():143-53. PubMed ID: 25641666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abstinence from Chronic Methylphenidate Exposure Modifies Cannabinoid Receptor 1 Levels in the Brain in a Dose-dependent Manner.
    Connor C; Hamilton J; Robison L; Hadjiargyrou M; Komatsu D; Thanos P
    Curr Pharm Des; 2022; 28(4):331-338. PubMed ID: 33504296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery from behavior and developmental effects of chronic oral methylphenidate following an abstinence period.
    Martin C; Fricke D; Vijayashanthar A; Lowinger C; Koutsomitis D; Popoola D; Hadjiargyrou M; Komatsu DE; Thanos PK
    Pharmacol Biochem Behav; 2018 Sep; 172():22-32. PubMed ID: 30030127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescent social defeat alters N-methyl-D-aspartic acid receptor expression and impairs fear learning in adulthood.
    Novick AM; Mears M; Forster GL; Lei Y; Tejani-Butt SM; Watt MJ
    Behav Brain Res; 2016 May; 304():51-9. PubMed ID: 26876136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment and abstinence from methylphenidate exposure dose-dependently changes glucose metabolism in the rat brain.
    Richer K; Hamilton J; Delis F; Martin C; Fricke D; Yao R; Sajjad M; Blum K; Hadjiargyrou M; Komatsu D; Thanos PK
    Brain Res; 2022 Apr; 1780():147799. PubMed ID: 35074404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of [3H]MK801 binding to rat brain NMDA receptors after the administration of a convulsant drug and an adenosine analogue: a quantitative autoradiographic study.
    Giraldez L; Girardi E
    Neurochem Res; 1998 Oct; 23(10):1327-36. PubMed ID: 9804290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief and extended abstinence from chronic oral methylphenidate treatment produces reversible behavioral and physiological effects.
    Kalinowski L; Connor C; Somanesan R; Carias E; Richer K; Smith L; Martin C; Mackintosh M; Popoola D; Hadjiargyrou M; Komatsu DE; Thanos PK
    Dev Psychobiol; 2020 Mar; 62(2):170-180. PubMed ID: 31456229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asenapine exerts distinctive regional effects on ionotropic glutamate receptor subtypes in rat brain.
    Tarazi FI; Choi YK; Gardner M; Wong EH; Henry B; Shahid M
    Synapse; 2009 May; 63(5):413-20. PubMed ID: 19177511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens.
    Hussain N; Flumerfelt BA; Rajakumar N
    Neuroscience; 2001; 102(2):391-9. PubMed ID: 11166125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the levels of NMDA receptor subunit mRNA and the bindings of [3H]MK-801 in rat brain by chronic infusion of subtoxic dose of MK-801.
    Oh S; Kim YH; Hann HJ; Lee HL; Choi HS; Kim HS; Ho IK
    Neurochem Res; 2001 May; 26(5):559-65. PubMed ID: 11513485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MK-801 blocks the development of sensitization to the locomotor effects of methylphenidate.
    Gaytan O; Nason R; Alagugurusamy R; Swann A; Dafny N
    Brain Res Bull; 2000 Apr; 51(6):485-92. PubMed ID: 10758338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
    Levin ED; Tizabi Y; Rezvani AH; Caldwell DP; Petro A; Getachew B
    Brain Res; 2005 Apr; 1041(2):132-42. PubMed ID: 15829222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic administration of MK-801 upon local cerebral glucose utilisation and ligand binding to the NMDA receptor complex.
    Kurumaji A; Ikeda M; Dewar D; McCormack AG; McCulloch J
    Brain Res; 1991 Nov; 563(1-2):57-65. PubMed ID: 1838495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abstinence following intermittent methylphenidate exposure dose-dependently modifies brain glucose metabolism in the rat brain.
    Arnavut E; Hamilton J; Yao R; Sajjad M; Hadjiargyrou M; Komatsu D; Thanos PK
    Synapse; 2022 Aug; 76(9-10):17-30. PubMed ID: 35730134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA receptor antagonist disrupts acute and chronic effects of methylphenidate.
    Yang P; Swann A; Dafny N
    Physiol Behav; 2000 Oct 1-15; 71(1-2):133-45. PubMed ID: 11134695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-related effects of MK-801 on acute and chronic methylphenidate administration.
    Sripada S; Gaytan O; Al-rahim S; Swann A; Dafny N
    Brain Res; 1998 Dec; 814(1-2):78-85. PubMed ID: 9838055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.